Results 211 to 220 of about 411,997 (358)
Nationwide Study on the Cervical Cancer Screening Pathway in Estonia
Cervical cancer remains a significant burden despite being preventable, largely due to inadequate screening participation and poor follow‐up of high‐risk women. Here, the authors investigated follow‐up rates among women who tested positive for high‐risk human papillomavirus (hr‐HPV) infection in primary screening in Estonia. Data show that more than 57
Aleksandra Šavrova +6 more
wiley +1 more source
Informative High-Risk HPV Genotyping in Cervical Cancer Screening: Integrated Analysis of Cytology and p16/Ki67 Dual Staining. [PDF]
Trzeszcz M +5 more
europepmc +1 more source
Lung cancer is detected primarily through screening, incidental findings, or presentation with symptoms. In Japan, the impact of detection pathway on prognosis is poorly understood, limiting evaluation of screening effectiveness. The authors of the present study analyzed Japanese National Cancer Registry data, comparing clinical characteristics and net
Ryo Koto +7 more
wiley +1 more source
Human papillomavirus-based vs. cytology for cervical cancer screening: a systematic review with meta-analysis. [PDF]
da Rocha KC +3 more
europepmc +1 more source
Neoadjuvant endocrine therapy (NET) can help prevent metastases and improve survival in patients with hormone receptor‐positive (HR+) breast cancer. Identifying which HR+ patients will benefit from NET, however, remains challenging. Here, in a patient cohort in the Netherlands, the authors evaluated tumor‐stroma ratio (TSR) and magnetic resonance ...
Layla Andour +8 more
wiley +1 more source
Real-World Performance of HPV DNA-Based Screening in Health Resource-Limited Areas of China: A Multicenter Implementation Study. [PDF]
Jia X +9 more
europepmc +1 more source
Uncertainty has persisted over whether human papillomavirus (HPV) testing outperforms high‐quality cytology in real‐world cervical cancer screening programs. To address this, Denmark launched a nationwide trial in 2021, implementing an HPV‐based screening strategy using specialized algorithms integrated with molecular and cytology triage to optimize ...
Jesper Bonde +12 more
wiley +1 more source

